Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AC Immune SA - Common Stock (NQ:ACIU)

2.710 -0.020 (-0.73%)
Delayed Quote Updated: 12:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AC Immune SA - Common Stock

< Previous 1 2 3 Next >
News headline image
AC Immune Parkinson’s Vaccine Study Meets Safety, Immunogenicity Goals ↗
AC Immune (NASDAQ:ACIU) reported results from Part 1 of its VacSYn Phase II trial evaluating ACI-7104.056, an active immunotherapy designed to target aggregated alpha-synuclein in early Parkinson’s... 
Via MarketBeat
News headline image
Why AC Immune Stock Zoomed Almost 15% Higher Today ↗
It's getting a cash infusion from its giant pharmaceutical partner. 
Via The Motley Fool
News headline image
Unusual volume stocks in Friday's session ↗
Unusual volume stocks are being observed in Friday's session. 
Via Chartmill
News headline image
Why Is AC Immune Stock Up Over 23% Today? ↗
ACIU shares surged over 23% after the company announced positive results from an interim Phase 2 study. 
Via Stocktwits
News headline image
Why Shares of AC Immune Jumped This Week ↗
The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Eliminating Some Screened Stocks ↗
Commodity prices regularly swing 25-30% or more in any given year. When this happens, the financial health of these firms can get dicey very quickly, given the amount of capital investment it requires... 
Via Talk Markets
Topics Stocks / Equities
News headline image
S&P 500 Moves Lower; US Crude Oil Inventories Increase ↗
 
Via Benzinga
Topics Stocks
News headline image
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients ↗
AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinson's disease. 
Via Benzinga
News headline image
Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ACIU Stock Earnings: AC Immune Misses EPS for Q1 2024 ↗
ACIU stock results show that AC Immune missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Gold Down Over 1%; AC Immune Shares Spike Higher ↗
 
Via Benzinga
News headline image
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday? ↗
Unlocking hope for Alzheimer's with ACI-24.060. Takeda's agreement with AC Immune targets toxic forms of Abeta, potentially slowing disease progression. 
Via Benzinga
News headline image
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Crude Oil Surges Over 1%; Amprius Technologies Shares Plunge ↗
 
Via Benzinga
News headline image
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today? ↗
TransCode Therapeutics stock is down on Monday after the company announced plans for a shareholder meeting for RNAZ investors. 
Via InvestorPlace
News headline image
Why Is Safe & Green Development (SGD) Stock Down 5% Today? ↗
Safe & Green Development stock is down on Monday as SGD investors learn of a Form D filing with the SEC for a securities sale. 
Via InvestorPlace
Topics Regulatory Compliance
News headline image
Why Is AC Immune (ACIU) Stock Up 45% Today? ↗
AC Immune stock is up on Monday after as investors in ACIU react to a new collaboration agreement with Takeda Pharmaceutical. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
News headline image
ACIU Stock Earnings: AC Immune Beats EPS, Beats Revenue for Q4 2023 ↗
ACIU stock results show that AC Immune beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial ↗
AC Immune SA's (NASDAQ: ACIU) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 (JNJ-64042056) in patients with... 
Via Benzinga
News headline image
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth ↗
Although growth penny stocks present extraordinary risks, if you exercise meticulous care, these ideas might be worth a shot. 
Via InvestorPlace
News headline image
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others ↗
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this  
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.